Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
Study Details
Study Description
Brief Summary
The primary objective of this study is to compare the efficacy of PDL and the 1064-nm Nd:YAG laser in the treatment of facial redness.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: YAG laser
|
Procedure: Pulse Dye Laser/YAG laser
This study involves treatments with two types of lasers, Pulsed dye lasers (PDL) and the 1064 nm Nd: YAG. Both lasers are FDA approved to treat vascularities in the skin.
|
Active Comparator: Pulse Dye Laer
|
Procedure: Pulse Dye Laser/YAG laser
This study involves treatments with two types of lasers, Pulsed dye lasers (PDL) and the 1064 nm Nd: YAG. Both lasers are FDA approved to treat vascularities in the skin.
|
Outcome Measures
Primary Outcome Measures
- Rating on global improvement scale [four months]
Non-treating dermatologists will rate each side of the face using a global improvement scale to evaluate the effectiveness of the two treatments.
- Spectrophotometer measurement [four months]
Spectrophotometer measurement as the percent resolution on each follow up visit compared to baseline visit
Secondary Outcome Measures
- Patient satisfaction [four months]
Patients will record satisfaction on the questionnaires provided
- Recorded discomfort [four months]
Subjects will record discomfort using a 10-point scale
- Adverse events [four months]
Any adverse events will be recorded
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy patients 18-55 years of age with erythematotelangiectatic rosacea (as verified by the the PI).
-
Subjects who are willing to provide informed consent for participation in the study.
Exclusion Criteria:
-
Pregnant or lactating individuals
-
Subjects who are unable to understand the protocol or to give informed consent.
-
Subjects who have a known history of photosensitive conditions (e.g. Systemic lupus, polymorphous light eruption)
-
Subjects who have facial telangiectasia of diameter greater than 2 mm.
-
Subject who have significant (as determined by the PI) acute inflammatory papules, pustules, and vesicle involving the central face.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Northwestern University Feinberg School of Medicine, Department of Dermatology | Chicago | Illinois | United States | 60611 |
Sponsors and Collaborators
- Northwestern University
Investigators
- Principal Investigator: Murad Alam, MD, Northwestern University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- STU55489